2026-01-22 - Analysis Report
**Company Overview:** International Business Machines Corporation (IBM) is an American multinational technology and consulting company that was founded in 1911.

**Return Rate Comparison:**
- Review Stock (IBM): 124.81%
- Compare Stock (S&P 500, VOO): 91.55%
- Divergence (last day): 33.26% (difference in cumulative return)
- Relative Divergence: 83.80% (current position when the minimum-maximum fluctuation range is set to 100)

**Performance Analysis:**
- Cumulative Returns:
  | Period | IBM | VOO | Divergence |
  | --- | --- | --- | --- |
  | 2016-2018 | -20.00% | N/A | N/A |
  | 2017-2019 | -24.00% | N/A | N/A |
  | 2018-2020 | -10.00% | N/A | N/A |
  | 2019-2021 | 13.00% | N/A | N/A |
  | 2020-2022 | -1.00% | N/A | N/A |
  | 2021-2023 | 22.00% | N/A | N/A |
  | 2022-2024 | 51.00% | N/A | N/A |
  | 2023-2025 | 129.00% | N/A | N/A |
- Market Risk Indicator (MRI): 0.80 (High Investment Recommended)

**Recent Stock Price Fluctuations:**
- Daily Prices:
  | Close | Last-Market | SMA |
  | --- | --- | --- |
  | $297.54 | $297.54 | N/A |
- Simple Moving Averages:
  | 5-day | 20-day | 60-day |
  | --- | --- | --- |
  | $300.31 | $301.49 | $304.11 |

**RSI, PPO, and Delta Analysis:**
- Market Risk Indicator (MRI): 0.80
- RSI: 47.67
- PPO: -0.20
- 7-day Rank change: 16 (+) (rank up)
- 7-day Dynamic Expected Return change: 1.00 (+) (improving)
- Recent (20 days) relative divergence change: 1.40 (+) (improving)
- Expected Return: -6.60% (Expected excess return compared to S&P 500 if invested long-term)

**Recent News & Significant Events:**
- Analyst are debating whether to buy the dip in IBM stock.
- After yesterday's drop, some analysts are recommending buying IBM stock.
- Mark your calendars for January 28 for a potential stock price movement.
- Three reasons to buy IBM stock now.
- Following Jefferies' AI-Focused upgrade, the bull case for International Business Machines (IBM) could change.

**Analyst Opinions:**
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
  - Opinions: 19
  - Target Price (avg/high/low): $304.00 / $375.00 / $198.00

**Recent Earnings Analysis:**
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-23 | $1.87 | $16.33B |
| 2025-07-24 | $2.36 | $16.98B |
| 2025-04-24 | $1.14 | $14.54B |
| 2024-10-30 | -$0.36 | $14.97B |

**Financial Information:**
* Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |
* Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $27.91B | 6.25% |
| 2025-06-30 | $27.51B | 7.98% |
| 2025-03-31 | $26.88B | 3.92% |
| 2024-12-31 | $27.31B | 10.67% |
| 2024-09-30 | $24.45B | -1.35% |

**Comprehensive Analysis (Summary of previous items):**
Overall, IBM's stock price has shown significant growth in recent years, outperforming the S&P 500. The current market risk indicator is 0.80, indicating a high investment recommendation. The stock price continues to fluctuate, with recent moving averages indicating a potential bounce. Analyst opinions are divided, but overall they suggest a buy recommendation. The company's earnings have been improving, with a recent revenue increase of 16.33 billion for the quarter. The equity and ROE figures indicate a stable position for the company.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.